CARDIOGENOL C HYDROCHLORIDE;4-(2-HYDROXYETHYLAMINO)-2-(4-METHOXYPHENYLAMINO)-PYRIMIDINE HYDROCHLORIDE;2-[[2-[(4-Methoxyphenyl)aMino]-4-pyriMidinyl]aMino]ethanol Hydrochloride;2-[[2-[(4-Methoxyphenyl)amino]-4-pyrimidinyl]amino]ethanol hydrochloride (1:1);Ethanol, 2-[[2-[(4-methoxyphenyl)amino]-4-pyrimidinyl]amino]-, hydrochloride (1:1);Cardiogenol C hydrochloride(b);Cardiogenol C hydrochloride, 10 mM in DMSO;Cardiogen (Myocardium)
Cardiogenol C hydrochloride is a potent cell-permeable pyrimidine-based inducer that promotes the differentiation of embryonic stem cells (ESCs) into cardiomyocytes (EC50 = 100 nM); it also exerts cardiomyogenic effects on lineage-committed progenitor cells within a limited plasticity range; it serves as a valuable cardiomyogenic reagent and can be used in animal models as a tool to enhance cardiac repair in cell transplantation studies; it significantly increases the expression of cardiac markers such as atrial natriuretic factor (ANF/NPPA) and NKX2-5 in P19 and C2C12 cells, respectively; it upregulates cardiac Nav1.5 sodium channel protein expression in a dose-dependent manner in C2C12 cells; it promotes the development of beating cardiomyocytes in cardiovascular progenitor cell-derived cardiac bodies; it enhances myocardial differentiation and increases the percentage of cardiac bodies (CBs) containing beating cardiomyocytes when added from day 0 of differentiation.